2002 Clinical Trials Concentrates 
The Cannigma
MAY 17, 2022
A 2002 study found that smoking cannabis increased blood flow in the frontal lobe, an area that’s thought to play an important role in abstract thought, creative thinking and sensory processing. Type I cannabis’ high concentration of THC can increase anxiety or drowsiness in some people, which isn’t conducive for artistic creation.
The Cannigma
AUGUST 14, 2022
A flow state is when all of your attention is concentrated on the task at hand, to the point that the world outside flows away. A 2002 study found that cannabis increases blood flow to the frontal lobe of the brain. Being focused is not the same thing as being in a flow state. Focus is like a spotlight you shine on a task.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Cannigma
DECEMBER 12, 2022
Clinical research: Research is focusing on 5-MeO-DMT use in depression and anxiety. Current clinical trials are underway using a synthetic nasal spray of 5-MeO-DMT in patients with major depressive disorder. As such, there have been numerous clinical trials using ketamine. A typical dose is 150-500 mcg.
Green Relief
MAY 13, 2018
The benefits of CBD-rich cannabis concentrates for chronic traumatic encephalopathy (CTE) are well-known among football players and other pro athletes. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. But the U.S. BY MARTIN A.
Green Relief
MAY 12, 2018
The benefits of CBD-rich cannabis concentrates for chronic traumatic encephalopathy (CTE) are well-known among football players and other pro athletes. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. But the U.S. BY MARTIN A.
Cannabis Law Report
JULY 12, 2019
Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval. 2002 Jun;42(8):993-1007.
Cannabis Law Report
NOVEMBER 24, 2021
Its use in China, Tibet, India, Nepal, Japan (McPartland and Hegman 2018 , Touw 1981 ), Ancient Greece and Rome (Butrica 2002 ), and Iran, Iraq, Turkey, Syria, and the Balkans (McPartland and Hegman 2018 ; Lozano 1997 ; Aldrich 1997 ) goes back thousands of years. Bonini et al. 7) and 2018 ( n ?=?4),
Expert insights. Personalized for you.
130 
Let's personalize your content